# Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)

> **NCT01807624** · PHASE2 · COMPLETED · sponsor: **St. Renatus, LLC** · enrollment: 24 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Tetracaine HCl 3% and Oxymetazoline HCl 0.05%

## Key facts

- **NCT ID:** NCT01807624
- **Lead sponsor:** St. Renatus, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-08-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807624, "Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01807624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*